Acyl dihydropyrazolo[1,5-a]pyrimidinones as metabotropic glutamate receptor 5 positive allosteric modulators

被引:5
|
作者
Malosh, Chrysa [1 ,2 ,3 ,4 ]
Turlington, Mark [1 ,2 ,3 ,4 ]
Bridges, Thomas M. [1 ,2 ,3 ]
Rook, Jerri M. [1 ,2 ,3 ]
Noetzel, Meredith J. [1 ,2 ,3 ]
Vinson, Paige N. [1 ,2 ,3 ]
Steckler, Thomas [5 ]
Lavreysen, Hilde [5 ]
Mackie, Claire [6 ]
Bartolome-Nebreda, Jose M. [7 ]
Conde-Ceide, Susana [7 ]
Martinez-Viturro, Carlos M. [7 ]
Piedrafita, Maria [7 ]
Sanchez-Casado, M. Rosa [7 ]
Macdonald, Gregor J. [5 ]
Daniels, J. Scott [1 ,2 ,3 ]
Jones, Carrie K. [1 ,2 ,3 ]
Niswender, Colleen M. [1 ,2 ,3 ]
Conn, P. Jeffrey [1 ,2 ,3 ]
Lindsley, Craig W. [1 ,2 ,3 ,4 ]
Stauffer, Shaun R. [1 ,2 ,3 ,4 ]
机构
[1] Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Vanderbilt Ctr Neurosci Drug Discovery, Med Ctr, Nashville, TN 37232 USA
[3] Vanderbilt Specialized Chem Ctr Probe Dev MLPCN, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA
[5] Janssen Res & Dev, Neurosci, B-2340 Beerse, Belgium
[6] Janssen Res & Dev, Discovery Sci ADME Tox, Toledo 45007, Spain
[7] Janssen Res & Dev, Neurosci Med Chem, Toledo 45007, Spain
关键词
Metabotropic glutamate receptor 5 (mGlu(5)); Positive allosteric modulator (PAM); NMDA-RECEPTOR; DISCOVERY; SERIES; SAR;
D O I
10.1016/j.bmcl.2015.10.009
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report the optimization of a series of metabotropic glutamate receptor 5 (mGlu(5)) positive allosteric modulators (PAMs) from an acyl dihydropyrazolo[1,5-a]pyrimidinone class. Investigation of exocyclic amide transpositions with this unique 5,6-bicyclic core were conducted in attempt to modulate physicochemical properties and identify a suitable backup candidate with a reduced half-life. A potent and selective PAM, 1-(2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrimidin-4(5H)-yl) ethanone (9a, VU0462807), was identified with superior solubility and efficacy in the acute amphetamine-induced hyperlocomotion (AHL) rat model with a minimum effective dose of 3 mg/kg. Attempts to mitigate oxidative metabolism of the western phenoxy of 9a through extensive modification and profiling are described. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5115 / 5120
页数:6
相关论文
共 50 条
  • [21] Fragment-Based Approaches for Allosteric Metabotropic Glutamate Receptor (mGluR) Modulators
    Orgovan, Zoltan
    Ferenczy, Gyorgy G.
    Keseru, Gyorgy M.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (19) : 1768 - 1781
  • [22] SAR Studies on mGlu5 Receptor Positive Allosteric Modulators (2003-2013)
    Hao, Junliang
    Xiong, Hui
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (15) : 1789 - 1841
  • [23] Identification and optimisation of a series of tetrahydrobenzotriazoles as metabotropic glutamate receptor 5-selective positive allosteric modulators that improve performance in a preclinical model of cognition
    Ellard, John M.
    Madin, Andrew
    Philps, Oliver
    Hopkin, Mark
    Henderson, Scott
    Birch, Louise
    O'Connor, Desmond
    Arai, Tohru
    Takase, Kazuma
    Morgan, Louise
    Reynolds, David
    Talma, Sonia
    Howley, Eimear
    Powney, Ben
    Payne, Andrew H.
    Hall, Adrian
    Gartlon, Jane E.
    Dawson, Lee A.
    Castro, Luis
    Atkinson, Peter J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (24) : 5792 - 5796
  • [24] Combining bioactivity and affinity to design of positive allosteric modulators of the metabotropic glutamate receptor using 3D-QSAR
    Hao, Chun-Zhi
    Yu, Liang-Min
    Xia, Shu-Wei
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (06): : 1880 - 1885
  • [25] Metabotropic glutamate receptor 5 (mGlu5)-positive allosteric modulators differentially induce or potentiate desensitization of mGlu5 signaling in recombinant cells and neurons
    Hellyer, Shane D.
    Albold, Sabine
    Sengmany, Kathy
    Singh, Junaid
    Leach, Katie
    Gregory, Karen J.
    JOURNAL OF NEUROCHEMISTRY, 2019, 151 (03) : 301 - 315
  • [26] In vitro binding of a radio-labeled positive allosteric modulator for metabotropic glutamate receptor subtype 5
    Zysk, John R.
    Spear, Nathan
    Fieles, William
    Stein, Mark M.
    Sygowski, Linda S.
    King, Megan M.
    Hoesch, Valerie
    Hastings, Richard
    Brockel, Becky
    Do, Mylinh
    Strom, Peter
    Gadient, Reto
    Chhajlani, Vijay
    Elmore, Charles S.
    Maier, Donna L.
    SYNAPSE, 2013, 67 (03) : 135 - 144
  • [27] 4-(1-Phenyl-1H-pyrazol-4-yl)quinolines as novel, selective and brain penetrant metabotropic glutamate receptor 4 positive allosteric modulators
    Jimenez, Hermogenes N.
    Liu, Kevin G.
    Hong, Sang-Phyo
    Reitman, Michael S.
    Uberti, Michelle A.
    Bacolod, Maria D.
    Cajina, Manuel
    Nattini, Megan
    Sabio, Michael
    Doller, Dario
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (09) : 3235 - 3239
  • [28] N-Aryl Piperazine Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators Possess Efficacy in Preclinical Models of NMDA Hypofunction and Cognitive Enhancement
    Gregory, K. J.
    Herman, E. J.
    Ramsey, A. J.
    Hammond, A. S.
    Byun, N. E.
    Stauffer, S. R.
    Manka, J. T.
    Jadhav, S.
    Bridges, T. M.
    Weaver, C. D.
    Niswender, C. M.
    Steckler, T.
    Drinkenburg, W. H.
    Ahnaou, A.
    Lavreysen, H.
    Macdonald, G. J.
    Bartolome, J. M.
    Mackie, C.
    Hrupka, B. J.
    Caron, M. G.
    Daigle, T. L.
    Lindsley, C. W.
    Conn, P. J.
    Jones, C. K.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 347 (02): : 438 - 457
  • [29] Mechanisms Underlying Allosteric Molecular Switches of Metabotropic Glutamate Receptor 5
    Llinas del Torrent, Claudia
    Casajuana-Martin, Nil
    Pardo, Leonardo
    Tresadern, Gary
    Perez-Benito, Laura
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2019, 59 (05) : 2456 - 2466
  • [30] Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2
    Farinha, A.
    Lavreysen, H.
    Peeters, L.
    Russo, B.
    Masure, S.
    Trabanco, A. A.
    Cid, J.
    Tresadern, G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (09) : 2383 - 2396